Net sales and net income saw strong year-over-year growth, with Core EBITDA and margins improving. The group strengthened its capital structure through refinancing and bond issuance, while U.S. sales remained the largest contributor.Original document: Galderma Group AG [GALD] Interim report — Jul…
Net sales and net income saw strong year-over-year growth, with Core EBITDA and margins improving. The group strengthened its capital structure through refinancing and bond issuance, while U.S. sales remained the largest contributor.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.